{"nct_id":"NCT06623422","title":"A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-10-21","start_date_type":"ACTUAL","primary_completion_date":"2033-05-16","primary_completion_date_type":"ESTIMATED","completion_date":"2038-01-26","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}